Integra Lifesciences Holdings (IART) Leases (2010 - 2026)

Integra Lifesciences Holdings' Leases history runs 12 years deep, the most recent figure standing at $137.2 million for Q1 2026.

• In Q1 2026, Leases fell 0.91% year-over-year to $137.2 million; the TTM figure through Mar 2026 stood at $137.2 million (down 0.91% YoY), while the FY2025 annual figure was $140.6 million, down 2.41% from the prior year.
• Leases came in at $137.2 million for Q1 2026 at Integra Lifesciences Holdings, down from $140.6 million in the prior quarter.
• In the past five years, Leases ranged from a high of $156.8 million in Q3 2023 to a low of $81.6 million in Q1 2022.
• A 5-year average of $141.9 million and a median of $146.3 million in 2024 frame the typical range for Leases.
• Across the five-year window, Leases declined 10.45% in 2022 and jumped 79.45% in 2023, its largest moves.
• Integra Lifesciences Holdings' Leases stood at $148.3 million in 2022, then rose by 5.33% to $156.2 million in 2023, then declined by 7.77% to $144.0 million in 2024, then fell by 2.41% to $140.6 million in 2025, then declined by 2.4% to $137.2 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $137.2 million, $140.6 million, and $138.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison